BioClinica expands imaging services in Europe with two new offices

By Zachary Brennan

- Last updated on GMT

Related tags Medical imaging Medicine Clinical trial

BioClinica expands imaging services in Europe with two new offices
BioClinica has opened offices in London and Munich to provide its European clients with expanded clinical trial services including medical imaging, site training and support, and eClinical product lines.

The combined space of 1,400 square meters across the two sites will specifically focus on medical imaging services, including an advanced image analysis center for BioClinica’s network of European radiologists and imaging specialists. 

As far as why this additional space may be necessary, John Hubbard, CEO of BioClinica, told “Imaging endpoints and biomarkers are becoming increasingly important as primary and secondary endpoints for demonstrating efficacy and safety in clinical trials. This is reflected in the current growth of the medical imaging sector at approximately 7-10% annually​.” 

Medical imaging can also provide early insight for the diagnosis, prognosis, and progression of complex diseases, which can help sponsors make decisions on trial enrollment and the advancement of pipeline candidates, Hubbard said, noting this is “especially true in the rapidly growing therapeutic areas of oncology, inflammatory disease, musculoskeletal disease, and neurological disorders​.” 

In addition to the imaging services, BioClinica’s eClinical Solutions business will also operate from these two new offices, Hubbard said. “We are seeing a high level of interest in our clinical technology products, including OnPoint CTMS (clinical trial management system) and Compass (intelligent risk based monitoring), designed to help sponsors run faster, more efficient clinical trials​.” 

David Herron, BioClinica’s President of Medical Imaging, Cardiovascular Safety, and Molecular Markers, added: “Our expansion will provide the resources needed for regional scientific and medical experts to assemble and deliver high quality central review of imaging data for multisite trials in Europe.”

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more